Acceleron Gets $30M Series F For Anemia, Cancer, DMD Trials
By Trista Morrison
Wednesday, December 28, 2011
Acceleron Pharma Inc. raised $30 million in its first major venture round since 2007, tapping a syndicate of existing investors to supplement recent partnering income.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.